簡(jiǎn)要描述:愛(ài)必信特色產(chǎn)品線(全部現(xiàn)貨):二抗、標(biāo)簽抗體、對(duì)照抗體;WB相關(guān):ECL發(fā)光液、預(yù)染marker、預(yù)制膠;IHC相關(guān):二抗試劑盒、組化筆;IP/CoIP試劑盒;細(xì)胞因子、信號(hào)通路調(diào)節(jié)劑;血清、BSA、蛋白酶K、CTB、TTX、CEE;凋亡試劑盒、呼吸爆發(fā)試劑盒;動(dòng)植物提取物...
產(chǎn)品分類(lèi)
Product Category相關(guān)文章
Related Articles詳細(xì)介紹
品牌 | absin | 貨號(hào) | abs01044 |
---|---|---|---|
規(guī)格 | 5ug | 供貨周期 | 一周 |
概述 | |
---|---|
種屬 | Canine |
形態(tài) | Lyophilized from a 0.2 μm filtered concentrated solution in PBS, pH 7.4. |
來(lái)源 | Escherichia coli. |
氨基酸序列 | APTRSPTLVT RPSQHVDAIQ EALSLLNNSN DVTAVMNKAV KVVSEVFDPE GPTCLETRLQ LYKEGLQGSL TSLKNPLTMM ANHYKQHCPP TPESPCATQN INFKSFKENL KDFLFNIPFD CWKPVKK |
內(nèi)毒素水平 | Less than 1 EU/μg of rCaGM-CSF as determined by LAL method. |
活性 | Fully biologically active when compared to standard. The ED50 as determined by a cell proliferation assay using human TF-1 cells is less than 5 ng/ml, corresponding to a specific activity of > 2.0 × 105 IU/mg. |
Accession # | P48749 |
預(yù)期分子量 | Approximay 14.2 kDa, a single non-glycosylated polypeptide chain containing 127 amino acids. |
性能 | |
---|---|
溶解方法 | We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 °C. Further dilutions should be made in appropriate buffered solutions. |
保存方法 | This lyophilized preparation is stable at 2-8 °C, but should be kept at -20 °C for long term storage, preferably desiccated. Upon reconstitution, the preparation is stable for up to one week at 2-8 °C. For maximal stability, apportion the reconstituted preparation into working aliquots and store at -20 °C to -70 °C. Avoid repeated freeze/thaw cycles. |
純度 | > 95 % by SDS-PAGE and HPLC analyses. |
Gene IDs | 403923 |
參考文獻(xiàn) | |
---|---|
1. Wang JM, Chen ZG, Colotta F, et al. 1988. Behring Inst Mitt: 270-3.<br/>2. 1989. N Engl J Med, 320: 253-4.<br/>3. Nissen-Druey C. 1989. Nouv Rev Fr Hematol, 31: 99-101.<br/>4. Eager RandNemunaitis J. 2005. Mol Ther, 12: 18-27.<br/>5. Tran T, Fernandes DJ, Schuliga M, et al. 2005. Br J Pharmacol, 145: 123-31. |
產(chǎn)品咨詢(xún)
電話
微信掃一掃